Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BAXTER INTERNATIONAL INC
Report date January 31, 2025 · Filed February 04, 2025
Section 16 reporting ended · disclosed 2025-02-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 105,186 |
Reported balance
After 2025-01-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-01-31 · Tax withholding · Disposed 25,372 · Balance 105,186 F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA"). F2: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").
F2: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 15,418 · Balance 0 F1: Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 633 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 1,816 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 6,415 · Balance 0 F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F7: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 8,437 · Balance 0 F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F8: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F4: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F5: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F6: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F7: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F8: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2025 Filed Feb 4, 2025 21:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 25,372 | $32.56 | $826,112.32 |
DisclosureSEC source: 0001062993-25-001606 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · EVP, Group Pres, Kidney Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,186 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA"). F2 · balance_after: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:00 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 32,610 | $29.16 | $950,907.60 |
DisclosureSEC source: 0001062993-25-000127 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · EVP,Group Pres, Kidney Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,876 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 31, 2024 from the settlement of vested restricted stock units granted on June 1, 2023. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 15,202 | $34.08 | $518,084.16 |
DisclosureSEC source: 0001062993-24-011977 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · EVP,Group Pres, Kidney Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,282 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 3, 2024 from the settlement of vested restricted stock units granted on June 1, 2023. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 119,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005968 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · EVP,Group Pres, Kidney Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,761 F1 · shares: For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 106,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012907 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · EVP, Group Pres, Kidney Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,358 F1 · shares: Mr. Toth received a grant of restricted stock units (RSUs)in connection with his appointment as EVP and Group President, Kidney Care. The RSUs are scheduled to vest in three equal annual installments beginning on June 3, 2024, the first anniversary of the grant date, subject to the terms and conditions set forth in the Baxter International Inc. 2021 Equity Plan. However, this award grant will vest in full if (i) by December 31, 2024, the proposed separation of the Kidney Care business (comprised of the Renal Care and Acute Therapies businesses) as a separately traded company (the "Business Transaction") does not occur; or (ii) in connection with the consummation of the Business Transaction, Mr. Toth is not appointed as Chief Executive Officer of the new company, Kidney Co. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Shares · Derivative | 8,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013910 · form4.xml · derivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,437 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F8 · price: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F8 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F8 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Shares · Derivative | 6,415 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013910 · form4.xml · derivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,415 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F7 · price: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F7 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F7 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 1,816 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013910 · form4.xml · derivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,816 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F5 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 633 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013910 · form4.xml · derivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 633 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerCommon Stock | 15,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013910 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · derivative · entry 7 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,449 Underlying: Common Stock · 907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2021, February 15, 2022 and February 15, 2023. Vested shares will be delivered to the reporting person on vest date. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2021, February 15, 2022 and February 15, 2023. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · derivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · derivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,988 Underlying: Common Stock · 837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 848 | $176.15 | $149,375.20 |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,230 F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006357 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 11,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · derivative · entry 15 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,825 Underlying: Common Stock · 11,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F11 · derivative.exercise_date: Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units vest originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023. F11 · derivative.expiration_date: Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units vest originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 13,450 | $0.00 Strike: $146.91 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · derivative · entry 14 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,450 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 13, 2021, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 8,573 | $0.00 Strike: $131.77 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · derivative · entry 13 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,573 shares Expires 2026-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 8,794 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · derivative · entry 12 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,794 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 4,823 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · derivative · entry 11 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,823 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 5,748 | $174.19 | $1,001,244.12 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 10 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,702 F5 · shares: Represents shares withheld from vested RSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 11,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 9 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 12,388 | $174.19 | $2,157,865.72 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 8 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,856 F4 · shares: Represents shares withheld for payment of exercise price of $146.91 per share as well as payment of federal, state and payroll taxes due on settlement Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 13,450 | $146.91 | $1,975,939.50 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 7 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 7,521 | $174.19 | $1,310,082.99 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,794 F3 · shares: Represents shares withheld for payment of exercise price of $131.77 per share as well as payment of federal, state and payroll taxes due on settlement Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 8,573 | $131.77 | $1,129,664.21 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 7,232 | $174.19 | $1,259,742.08 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,742 F2 · shares: Represents shares withheld for payment of exercise price of $112.82 per share as well as payment of federal, state and payroll taxes due on settlement. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 8,794 | $112.82 | $992,139.08 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 3,514 | $174.19 | $612,103.66 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,180 F1 · shares: Represents shares withheld for payment of exercise price of $80.40 per share as well as payment of federal, state and payroll taxes due on settlement Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 4,823 | $80.40 | $387,769.20 |
DisclosureSEC source: 0001127602-20-030401 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 19:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 667 | $173.50 | $115,724.50 |
DisclosureSEC source: 0001127602-20-030041 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,871 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 19:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 1,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030041 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,538 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on November 16, 2017. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 18:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 11,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-024145 · form4.xml · derivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,594 Underlying: Common Stock · 11,594 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023, subject to accelerated vesting in certain circumstances. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023, subject to accelerated vesting in certain circumstances. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 13:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 119 | $111.28 | $13,241.80 |
DisclosureSEC source: 0001127602-20-013730 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,624 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 119 shares were sold in multiple transactions executed on the same day at prices ranging from $111.255 to $111.85. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 13:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 510 | $110.18 | $56,190.83 |
DisclosureSEC source: 0001127602-20-013730 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,743 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 510 shares were sold in multiple transactions executed on the same day at prices ranging from $110.045 to $110.86. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 13:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 996 | $109.33 | $108,892.78 |
DisclosureSEC source: 0001127602-20-013730 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 996 shares were sold in multiple transactions executed on the same day at prices ranging from $108.87 to $109.855. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · derivative · entry 7 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · derivative · entry 6 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886 Underlying: Common Stock · 837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · derivative · entry 5 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 873 | $145.90 | $127,370.70 |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · nonDerivative · entry 4 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,249 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · nonDerivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006771 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 2,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006167 · form4.xml · derivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723 Underlying: Restricted Stock Units · 2,723 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2021, February 15, 2022 and February 15, 2023. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2021, February 15, 2022 and February 15, 2023. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 18:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 13,450 | $0.00 Strike: $146.91 | $0.00 |
DisclosureSEC source: 0001127602-20-006167 · form4.xml · derivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,450 Underlying: Common Stock · 13,450 shares Expires 2027-02-13 F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 13, 2021, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 18:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,597 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-20-001296 · form4.xml · derivative · entry 3 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,794 Underlying: Common Stock · 1,597 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 18:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,597 | $145.00 | $231,565.00 |
DisclosureSEC source: 0001127602-20-001296 · form4.xml · nonDerivative · entry 2 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 18:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,597 | $112.82 | $180,173.54 |
DisclosureSEC source: 0001127602-20-001296 · form4.xml · nonDerivative · entry 1 Toth Christopher A. · CIK 0001753950 · SVP and Pres. Oncology Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.